CY1108809T1 - Μεθοδοι κατασκευης 6-[(4.5-διϋδρο-1η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1η-βενζιμιδαζολο-4-kapboniτριλιου και προτιμωμενη μορφη αλατος αυτου - Google Patents

Μεθοδοι κατασκευης 6-[(4.5-διϋδρο-1η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1η-βενζιμιδαζολο-4-kapboniτριλιου και προτιμωμενη μορφη αλατος αυτου

Info

Publication number
CY1108809T1
CY1108809T1 CY20091100189T CY091100189T CY1108809T1 CY 1108809 T1 CY1108809 T1 CY 1108809T1 CY 20091100189 T CY20091100189 T CY 20091100189T CY 091100189 T CY091100189 T CY 091100189T CY 1108809 T1 CY1108809 T1 CY 1108809T1
Authority
CY
Cyprus
Prior art keywords
imidazol
dihydro
amino
methyl
capbonitrile
Prior art date
Application number
CY20091100189T
Other languages
English (en)
Inventor
Jared Lynn Randall
Richard Alan Gibbs
Gregory Kent Bosch
Michael David Curtis
Li Sun
Nicholas Nikolaides
Original Assignee
The Board Of Regents Of The
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Regents Of The filed Critical The Board Of Regents Of The
Publication of CY1108809T1 publication Critical patent/CY1108809T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

6-[(4,5- διϋδρο-1Η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1 Η-βενζι-μιδαζολο-4-καρβονιτρίλιο ουσιαστικώς ελεύθερο του 2,3,7-τριαμινο-4,6-διμεθυλ-1,9-φαιναζινοδικαρβονιτριλίου και το άνυδρο μονοοξεικό άλας αυτού είναι χρήσιμα στη θεραπεία αλφα-2 προκαλούμενων διαταραχών όπως οφθαλμικής υπέρτασης.
CY20091100189T 2003-02-20 2009-02-18 Μεθοδοι κατασκευης 6-[(4.5-διϋδρο-1η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1η-βενζιμιδαζολο-4-kapboniτριλιου και προτιμωμενη μορφη αλατος αυτου CY1108809T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44881103P 2003-02-20 2003-02-20
US10/386,958 US20040167194A1 (en) 2003-02-20 2003-03-12 Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
EP04713336A EP1594862B1 (en) 2003-02-20 2004-02-20 Methods of making 6-[ (4,5-dihydro-1h-imidazol-2-yl)amino-] -7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form

Publications (1)

Publication Number Publication Date
CY1108809T1 true CY1108809T1 (el) 2014-04-09

Family

ID=32871636

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100189T CY1108809T1 (el) 2003-02-20 2009-02-18 Μεθοδοι κατασκευης 6-[(4.5-διϋδρο-1η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1η-βενζιμιδαζολο-4-kapboniτριλιου και προτιμωμενη μορφη αλατος αυτου

Country Status (9)

Country Link
US (2) US20040167194A1 (el)
EP (2) EP1594862B1 (el)
AT (1) ATE414700T1 (el)
AU (1) AU2004213458B2 (el)
CA (1) CA2517002C (el)
CY (1) CY1108809T1 (el)
DE (1) DE602004017838D1 (el)
ES (2) ES2482167T3 (el)
WO (1) WO2004074279A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456219B2 (en) * 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid
WO2004074234A1 (en) * 2003-02-20 2004-09-02 Lonza Ag Process for the preparation of n-substituted formamides
CN101437788A (zh) * 2006-05-10 2009-05-20 特瓦制药工业有限公司 还原7/9-硝基四环素衍生物的方法
US20110288089A1 (en) 2009-01-22 2011-11-24 Syngenta Crop Protection Llc Insecticidal compounds
CN102120731B (zh) * 2010-01-09 2015-01-07 浙江华海药业股份有限公司 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-(3-吗啉丙氧基)喹唑啉的新方法
US20150133516A1 (en) * 2013-11-13 2015-05-14 Brian K. Adams Methods and Compositions for Treating ADHD
CN105418519B (zh) * 2015-11-25 2018-10-02 高小春 具有抗肿瘤活性的吩嗪酰胺类化合物的合成及其应用
DK3638653T3 (da) * 2017-06-14 2022-03-07 Bayer Ag Fremgangsmåde til fremstilling af 3,4-dichlor-n-(2-cyanophenyl)-5-isothiazolcarboxamid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478858A (en) 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
DE4422370A1 (de) 1994-06-27 1996-01-04 Nsm Ag System zum bargeldlosen Spielen an geldbetätigten Unterhaltungsautomaten
EP0775134A4 (en) * 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
ZA9710581B (en) 1996-11-25 1998-06-12 Procter & Gamble Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivates.
ID24081A (id) * 1997-04-15 2000-07-06 Procter & Gamble Senyawa-senyawa 5-(2-imidazolinilamino) benzimidazol yang berguna sebagai agonis-agonis alfa-2-adrenoseptor
SK7792000A3 (en) * 1997-11-24 2001-01-18 Procter & Gamble 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as alpha-adrenoceptor agonists with improved metabolic stability
US6066740A (en) * 1997-11-25 2000-05-23 The Procter & Gamble Company Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives

Also Published As

Publication number Publication date
EP1594862A1 (en) 2005-11-16
US20060122248A1 (en) 2006-06-08
ES2318272T3 (es) 2009-05-01
WO2004074279A1 (en) 2004-09-02
AU2010201757A1 (en) 2010-05-20
ES2482167T3 (es) 2014-08-01
EP1953146B1 (en) 2014-04-30
DE602004017838D1 (de) 2009-01-02
US20040167194A1 (en) 2004-08-26
AU2004213458A1 (en) 2004-09-02
US7304084B2 (en) 2007-12-04
ATE414700T1 (de) 2008-12-15
AU2004213458B2 (en) 2010-03-04
CA2517002A1 (en) 2004-09-02
EP1594862B1 (en) 2008-11-19
CA2517002C (en) 2014-07-08
EP1953146A1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
CY1108809T1 (el) Μεθοδοι κατασκευης 6-[(4.5-διϋδρο-1η-ιμιδαζολ-2-υλ)αμινο-]-7-μεθυλ-1η-βενζιμιδαζολο-4-kapboniτριλιου και προτιμωμενη μορφη αλατος αυτου
NO2022001I1 (no) Pazopanib
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
ATE447561T1 (de) Substituierte aryl 1,4-pyrazin derivate
DK1171137T3 (da) Anvendelse af triacetyluridin til behandling af mitochondriale lidelser
DE602004016563D1 (de) Nukleierungsmittel
DE60333937D1 (de) Substituierte quinazolinone verbindungen
DE60206512D1 (de) Rapanycin29-enole
CY1112946T1 (el) 4-υδροξυβενζομορφανια
CY1112458T1 (el) Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου
CY1114873T1 (el) Παραγωγα ρετιναλης και μεθοδοι για τη χρηση αυτων στην αντιμετωπιση διαταραχων της ορασης
CY1111386T1 (el) Ενωσεις και μεθοδοι για αυξηση νευρογενεσης
DE602005020611D1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
SE9904377D0 (sv) Pharmaceutical combinations
ATE411981T1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE60211132D1 (de) 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
DK1220852T3 (da) Substituerede diazepaner
CY1106409T1 (el) Παραγωγα κινολινης
NO20060420L (no) 2-aminobenzoylderivater
DE60335610D1 (de) Neoplasma-spezifische antikörper und deren verwendungen
EA200401032A1 (ru) Антиинфарктные молекулы
ATE422885T1 (de) Cycloalkyläbü kondensierte indole